...
search icon
ser-img

Serina Therapeutics Inc, Common Stock

SER

ASQ

$5.5

+$0.23

(4.36%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$50.65M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
15.51K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.81 L
$14.57 H
$5.5

About Serina Therapeutics Inc, Common Stock

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameSERSectorS&P500
1-Week Return7.84%-1.91%-4.4%
1-Month Return13.64%-8.22%-10.77%
3-Month Return15.55%-5.01%-15.29%
6-Month Return-28.1%-10.62%-11.9%
1-Year Return-43.93%-3.17%2.9%
3-Year Return-82.16%1.04%20.61%
5-Year Return-80.56%37.23%84.18%
10-Year Return-94.4%81.65%144.64%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue54.00K3.04M500.00K142.00K-[{"date":"2020-12-31","value":1.78,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":16.45,"profit":true},{"date":"2023-12-31","value":4.67,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue1.28M150.00K145.00K171.00K-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":11.71,"profit":true},{"date":"2022-12-31","value":11.32,"profit":true},{"date":"2023-12-31","value":13.35,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(1.23M)2.89M355.00K(29.00K)-[{"date":"2020-12-31","value":-42.47,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":12.29,"profit":true},{"date":"2023-12-31","value":-1,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin(2272.22%)95.06%71.00%(20.42%)-[{"date":"2020-12-31","value":-2390.19,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":74.69,"profit":true},{"date":"2023-12-31","value":-21.48,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses9.18M4.67M2.77M9.93M17.05M[{"date":"2020-12-31","value":53.85,"profit":true},{"date":"2021-12-31","value":27.4,"profit":true},{"date":"2022-12-31","value":16.25,"profit":true},{"date":"2023-12-31","value":58.25,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(10.41M)(1.63M)(2.27M)(9.96M)(17.05M)[{"date":"2020-12-31","value":-1040700000,"profit":false},{"date":"2021-12-31","value":-163150800,"profit":false},{"date":"2022-12-31","value":-227036800,"profit":false},{"date":"2023-12-31","value":-996000000,"profit":false},{"date":"2024-12-31","value":-1704800000,"profit":false}]
Total Non-Operating Income/Expense-374.57K(425.86K)(5.41M)5.84M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":6.41,"profit":true},{"date":"2022-12-31","value":-7.29,"profit":false},{"date":"2023-12-31","value":-92.6,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(10.40M)(1.26M)(2.68M)(14.81M)(11.21M)[{"date":"2020-12-31","value":-1039900000,"profit":false},{"date":"2021-12-31","value":-126470300,"profit":false},{"date":"2022-12-31","value":-268210800,"profit":false},{"date":"2023-12-31","value":-1481100000,"profit":false},{"date":"2024-12-31","value":-1120700000,"profit":false}]
Income Taxes466.00K3.09K(250.04K)(8.00K)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":0.66,"profit":true},{"date":"2022-12-31","value":-53.66,"profit":false},{"date":"2023-12-31","value":-1.72,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-(1.27M)(2.43M)(14.80M)-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-126779700,"profit":false},{"date":"2022-12-31","value":-243207000,"profit":false},{"date":"2023-12-31","value":-1480300000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations-(1.26M)(2.68M)5.27M(11.21M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-24,"profit":false},{"date":"2022-12-31","value":-50.9,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-212.7,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(10.87M)(1.26M)(2.68M)(14.80M)(11.14M)[{"date":"2020-12-31","value":-1086500000,"profit":false},{"date":"2021-12-31","value":-126470300,"profit":false},{"date":"2022-12-31","value":-268210800,"profit":false},{"date":"2023-12-31","value":-1480300000,"profit":false},{"date":"2024-12-31","value":-1114100000,"profit":false}]
EPS (Diluted)(10.14)(8.05)(9.70)(13.72)(3.09)[{"date":"2020-12-31","value":-1014.45,"profit":false},{"date":"2021-12-31","value":-805.28,"profit":false},{"date":"2022-12-31","value":-969.69,"profit":false},{"date":"2023-12-31","value":-1371.85,"profit":false},{"date":"2024-12-31","value":-309.49,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SER
Cash Ratio 1.55
Current Ratio 2.40

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SER
ROA (LTM) -124.04%
ROE (LTM) -485.36%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SER
Debt Ratio Lower is generally better. Negative is bad. 0.92
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.10

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SER
Trailing PE NM
Forward PE NM
P/S (TTM) 975.49
P/B 85.22
Price/FCF NM
EV/R 0.00
EV/Ebitda 37.36

FAQs

What is Serina Therapeutics Inc share price today?

Serina Therapeutics Inc (SER) share price today is $5.5

Can Indians buy Serina Therapeutics Inc shares?

Yes, Indians can buy shares of Serina Therapeutics Inc (SER) on Vested. To buy Serina Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SER stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Serina Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Serina Therapeutics Inc (SER) via the Vested app. You can start investing in Serina Therapeutics Inc (SER) with a minimum investment of $1.

How to invest in Serina Therapeutics Inc shares from India?

You can invest in shares of Serina Therapeutics Inc (SER) via Vested in three simple steps:

  • Click on Sign Up or Invest in SER stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Serina Therapeutics Inc shares
What is Serina Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Serina Therapeutics Inc (SER) is $14.57. The 52-week low price of Serina Therapeutics Inc (SER) is $3.81.

What is Serina Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Serina Therapeutics Inc (SER) is 85.22

What is the Market Cap of Serina Therapeutics Inc?

The market capitalization of Serina Therapeutics Inc (SER) is $50.65M

What is Serina Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Serina Therapeutics Inc is SER

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top